Clinical Trial Detail

NCT ID NCT02685267
Title Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer (Doce/Enza)
Recruitment Unknown status
Gender male
Phase Phase II
Variant Requirements No
Sponsors Prostate Cancer Clinical Trials Consortium
Indications

prostate adenocarcinoma

Therapies

Docetaxel + Enzalutamide + Prednisone

Docetaxel + Prednisone

Age Groups: adult senior

No variant requirements are available.